FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2779576706> ?p ?o ?g. }

• W2779576706 abstract "To overcome unsatisfactory results of classical low-dose cytarabine (LDAC) of cytarabine ≤20 mg twice daily (BID) subcutaneously for 10 days for patients with elderly acute myeloid leukemia (eAML), we evaluated a modified LDAC (mLDAC) of cytarabine 20 mg/m2 BID subcutaneously plus etoposide 50 mg BID orally for 14 days. To determine its feasibility, we compared outcomes of 77 and 42 eAML patients who received, respectively, mLDAC and decitabine (DAC; 20 mg/m2 intravenously daily for 5 days), which has shown better outcomes compared to those of classical LDAC. Most of baseline characteristics of two groups were well balanced. The mLDAC group had a higher complete response (CR) rate compared to the DAC group (46.8% vs. 19.0%, P < 0.01). Unlike the classical LDAC, mLDAC induced CR in patients with adverse cytogenetics, with its rate similar to that of the DAC group (33.3% vs. 20.0%; P = 0.58). Meanwhile, mucositis, neutropenic fever and invasive aspergillosis were more frequently observed in the mLDAC group, with no difference in early mortality between two groups (P > 0.05). The median overall survival rates of the mLDAC and DAC groups were comparable (8.7 vs 8.3 months, respectively, P = 0.35), presumably because the advantage of higher CR rate in the mLDAC group was offset by beneficial effects of marrow response, which is observed dominantly in the DAC group. Our results suggested that the outcomes of classical LDAC could be improved by modest modifications, to be comparable to those of DAC." @default.
• W2779576706 created "2018-01-05" @default.
• W2779576706 creator A5014324967 @default.
• W2779576706 creator A5021692797 @default.
• W2779576706 creator A5026190297 @default.
• W2779576706 creator A5033356298 @default.
• W2779576706 creator A5034751203 @default.
• W2779576706 creator A5036020306 @default.
• W2779576706 creator A5044372572 @default.
• W2779576706 creator A5050292329 @default.
• W2779576706 creator A5055206475 @default.
• W2779576706 creator A5059291757 @default.
• W2779576706 creator A5061707434 @default.
• W2779576706 creator A5063799437 @default.
• W2779576706 creator A5065416055 @default.
• W2779576706 creator A5074128691 @default.
• W2779576706 creator A5081217020 @default.
• W2779576706 creator A5084426605 @default.
• W2779576706 creator A5086415059 @default.
• W2779576706 creator A5086500437 @default.
• W2779576706 date "2017-12-23" @default.
• W2779576706 modified "2023-10-09" @default.
• W2779576706 title "Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy" @default.
• W2779576706 cites W1185299649 @default.
• W2779576706 cites W1600365609 @default.
• W2779576706 cites W1913413628 @default.
• W2779576706 cites W1964598102 @default.
• W2779576706 cites W1965658643 @default.
• W2779576706 cites W1968626722 @default.
• W2779576706 cites W1973392550 @default.
• W2779576706 cites W1979969603 @default.
• W2779576706 cites W1984100015 @default.
• W2779576706 cites W1989345554 @default.
• W2779576706 cites W1994169292 @default.
• W2779576706 cites W2028578770 @default.
• W2779576706 cites W2035746883 @default.
• W2779576706 cites W2047435984 @default.
• W2779576706 cites W2054439285 @default.
• W2779576706 cites W2055884944 @default.
• W2779576706 cites W2058188142 @default.
• W2779576706 cites W2066762918 @default.
• W2779576706 cites W2068556430 @default.
• W2779576706 cites W2097192169 @default.
• W2779576706 cites W2098676216 @default.
• W2779576706 cites W2101725260 @default.
• W2779576706 cites W2106084333 @default.
• W2779576706 cites W2128812336 @default.
• W2779576706 cites W2144395887 @default.
• W2779576706 cites W2149058047 @default.
• W2779576706 cites W2149913986 @default.
• W2779576706 cites W2158804011 @default.
• W2779576706 cites W2159507916 @default.
• W2779576706 cites W2259204994 @default.
• W2779576706 cites W2279080061 @default.
• W2779576706 cites W2302206374 @default.
• W2779576706 cites W2341894622 @default.
• W2779576706 cites W2410041341 @default.
• W2779576706 doi "https://doi.org/10.18632/oncotarget.23629" @default.
• W2779576706 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5814177" @default.
• W2779576706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29464037" @default.
• W2779576706 hasPublicationYear "2017" @default.
• W2779576706 type Work @default.
• W2779576706 sameAs 2779576706 @default.
• W2779576706 citedByCount "1" @default.
• W2779576706 countsByYear W27795767062021 @default.
• W2779576706 crossrefType "journal-article" @default.
• W2779576706 hasAuthorship W2779576706A5014324967 @default.
• W2779576706 hasAuthorship W2779576706A5021692797 @default.
• W2779576706 hasAuthorship W2779576706A5026190297 @default.
• W2779576706 hasAuthorship W2779576706A5033356298 @default.
• W2779576706 hasAuthorship W2779576706A5034751203 @default.
• W2779576706 hasAuthorship W2779576706A5036020306 @default.
• W2779576706 hasAuthorship W2779576706A5044372572 @default.
• W2779576706 hasAuthorship W2779576706A5050292329 @default.
• W2779576706 hasAuthorship W2779576706A5055206475 @default.
• W2779576706 hasAuthorship W2779576706A5059291757 @default.
• W2779576706 hasAuthorship W2779576706A5061707434 @default.
• W2779576706 hasAuthorship W2779576706A5063799437 @default.
• W2779576706 hasAuthorship W2779576706A5065416055 @default.
• W2779576706 hasAuthorship W2779576706A5074128691 @default.
• W2779576706 hasAuthorship W2779576706A5081217020 @default.
• W2779576706 hasAuthorship W2779576706A5084426605 @default.
• W2779576706 hasAuthorship W2779576706A5086415059 @default.
• W2779576706 hasAuthorship W2779576706A5086500437 @default.
• W2779576706 hasBestOaLocation W27795767061 @default.
• W2779576706 hasConcept C104317684 @default.
• W2779576706 hasConcept C126322002 @default.
• W2779576706 hasConcept C141071460 @default.
• W2779576706 hasConcept C143998085 @default.
• W2779576706 hasConcept C150194340 @default.
• W2779576706 hasConcept C185592680 @default.
• W2779576706 hasConcept C190727270 @default.
• W2779576706 hasConcept C197934379 @default.
• W2779576706 hasConcept C2776694085 @default.
• W2779576706 hasConcept C2778041864 @default.
• W2779576706 hasConcept C2778119113 @default.
• W2779576706 hasConcept C2778461978 @default.
• W2779576706 hasConcept C2778496288 @default.
• W2779576706 hasConcept C2778729363 @default.
• W2779576706 hasConcept C2780235182 @default.

• next